Gang Niu

Q: What Schools Are Affiliated With Gang Niu

Gang Niu is affiliated with the following schools: Harbin Medical University, Peking University

Gang Niu's AcademicInfluence.com Rankings

Gang Niu

Chemistry

#4408

World Rank

#5488

Historical Rank

Inorganic Chemistry

#240

World Rank

#254

Historical Rank

Organic Chemistry

#725

World Rank

#822

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Gang Niu's Degrees

Bachelors Chemistry Peking University

Why Is Gang Niu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gang Niu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO2 -Based Nanoagent to Enhance Chemodynamic Therapy. (2018) (845)
Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. (2013) (564)
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. (2013) (538)
Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy. (2019) (490)
Single Continuous Wave Laser Induced Photodynamic/Plasmonic Photothermal Therapy Using Photosensitizer‐Functionalized Gold Nanostars (2013) (417)
Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors. (2018) (312)
Biomineralization-Inspired Synthesis of Copper Sulfide-Ferritin Nanocages as Cancer Theranostics. (2016) (290)
Sequential Drug Release and Enhanced Photothermal and Photoacoustic Effect of Hybrid Reduced Graphene Oxide-Loaded Ultrasmall Gold Nanorod Vesicles for Cancer Therapy. (2015) (285)
Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots. (2013) (283)
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. (2010) (282)
Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy. (2017) (272)
Efficient production and enhanced tumor delivery of engineered extracellular vesicles. (2016) (237)
Dye‐Loaded Ferritin Nanocages for Multimodal Imaging and Photothermal Therapy (2014) (237)
Ultrasmall Gold Nanorod Vesicles with Enhanced Tumor Accumulation and Fast Excretion from the Body for Cancer Therapy (2015) (229)
Chimeric ferritin nanocages for multiple function loading and multimodal imaging. (2011) (226)
Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self‐Assembled Metal‐Phenolic Network Nanoparticles (2018) (225)
Efficient Nanovaccine Delivery in Cancer Immunotherapy. (2017) (208)
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 (2016) (204)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy (2017) (198)
Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. (2013) (192)
Imaging of integrins as biomarkers for tumor angiogenesis. (2008) (191)
Triphase Interface Synthesis of Plasmonic Gold Bellflowers as Near-Infrared Light Mediated Acoustic and Thermal Theranostics (2014) (183)
Photosensitizer Loaded Nano-Graphene for Multimodality Imaging Guided Tumor Photodynamic Therapy (2014) (183)
Repurposing Cyanine NIR‐I Dyes Accelerates Clinical Translation of Near‐Infrared‐II (NIR‐II) Bioimaging (2018) (183)
Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles (2014) (182)
Tumor-Specific Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics. (2015) (161)
Why Integrin as a Primary Target for Imaging and Therapy (2011) (160)
Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy (2017) (160)
PET Imaging of Inflammation Biomarkers (2013) (159)
Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy. (2020) (159)
Near-Infrared-II (NIR-II) Bioimaging via Off-Peak NIR-I Fluorescence Emission (2018) (155)
Chelator-Free 64Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy (2014) (153)
Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer Therapy. (2018) (151)
Multimodal‐Imaging‐Guided Cancer Phototherapy by Versatile Biomimetic Theranostics with UV and γ‐Irradiation Protection (2016) (147)
Glucose Oxidase-Catalyzed Growth of Gold Nanoparticles Enables Quantitative Detection of Attomolar Cancer Biomarkers (2014) (144)
Gold nanoparticle-based activatable probe for sensing ultralow levels of prostate-specific antigen. (2013) (143)
Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy. (2018) (142)
Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. (2013) (138)
Aptamer-Drug Conjugates. (2015) (135)
68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging (2009) (132)
Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide. (2015) (131)
Self-Illuminating 64Cu-Doped CdSe/ZnS Nanocrystals for in Vivo Tumor Imaging (2014) (131)
Visualization of Protease Activity In Vivo Using an Activatable Photo-Acoustic Imaging Probe Based on CuS Nanoparticles (2014) (130)
Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. (2011) (129)
Smart Nanovesicle Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy. (2019) (129)
In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy. (2019) (129)
Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy. (2017) (128)
Impact of Semiconducting Perylene Diimide Nanoparticle Size on Lymph Node Mapping and Cancer Imaging. (2017) (127)
Intrinsically Radioactive [64Cu]CuInS/ZnS Quantum Dots for PET and Optical Imaging: Improved Radiochemical Stability and Controllable Cerenkov Luminescence (2014) (126)
An aptamer-targeting photoresponsive drug delivery system using "off-on" graphene oxide wrapped mesoporous silica nanoparticles. (2015) (125)
Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. (2012) (123)
Delayed Postconditioning Protects against Focal Ischemic Brain Injury in Rats (2008) (120)
Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy. (2017) (120)
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models (2009) (120)
Acetylcholinesterase-catalyzed hydrolysis allows ultrasensitive detection of pathogens with the naked eye. (2013) (117)
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging (2009) (116)
Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy (2017) (113)
Apoptosis Imaging: Beyond Annexin V (2010) (113)
Multiplexed NIR‐II Probes for Lymph Node‐Invaded Cancer Detection and Imaging‐Guided Surgery (2020) (108)
Tumor Hypoxia Imaging (2011) (107)
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer (2020) (107)
Multimodality imaging of the HER-kinase axis in cancer (2007) (105)
N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. (2011) (105)
Hybrid ferritin nanoparticles as activatable probes for tumor imaging. (2011) (105)
Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet (2012) (100)
Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics (2019) (100)
Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization. (2016) (98)
In Situ Polymerized Hollow Mesoporous Organosilica Biocatalysis Nanoreactor for Enhancing ROS‐Mediated Anticancer Therapy (2019) (98)
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. (2010) (97)
PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters. (2014) (96)
Glutathione-Responsive Self-Assembled Magnetic Gold Nanowreath for Enhanced Tumor Imaging and Imaging-Guided Photothermal Therapy. (2018) (95)
A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface. (2012) (94)
18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma (2012) (94)
Suppressing Nanoparticle-Mononuclear Phagocyte System Interactions of Two-Dimensional Gold Nanorings for Improved Tumor Accumulation and Photothermal Ablation of Tumors. (2017) (93)
Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy. (2018) (93)
Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles. (2012) (88)
Sticky nanoparticles: a platform for siRNA delivery by a bis(zinc(II) dipicolylamine)-functionalized, self-assembled nanoconjugate. (2012) (88)
Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma (2010) (86)
Design Considerations of Iron-Based Nanoclusters for Noninvasive Tracking of Mesenchymal Stem Cell Homing (2014) (81)
In vivo albumin labeling and lymphatic imaging (2014) (81)
Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging (2019) (81)
Yolk–Shell Nanostructure: An Ideal Architecture to Achieve Harmonious Integration of Magnetic–Plasmonic Hybrid Theranostic Platform (2017) (79)
Early-Stage Imaging of Nanocarrier-Enhanced Chemotherapy Response in Living Subjects by Scalable Photoacoustic Microscopy (2014) (79)
Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. (2015) (77)
Polymeric Materials for Theranostic Applications (2014) (76)
PET imaging of CXCR4 using copper-64 labeled peptide antagonist (2011) (75)
A Rationally Designed Semiconducting Polymer Brush for NIR‐II Imaging‐Guided Light‐Triggered Remote Control of CRISPR/Cas9 Genome Editing (2019) (74)
Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury (2013) (73)
PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2 (2012) (73)
Imaging of Urokinase-Type Plasminogen Activator Receptor Expression Using a 64Cu-Labeled Linear Peptide Antagonist by microPET (2008) (73)
Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy (2019) (73)
Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme (2008) (73)
Clinical Translation of a Dual Integrin αvβ3– and Gastrin-Releasing Peptide Receptor–Targeting PET Radiotracer, 68Ga-BBN-RGD (2017) (72)
Functional ferritin nanoparticles for biomedical applications (2017) (71)
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab (2009) (71)
In Vivo Labeling of Serum Albumin for PET (2014) (70)
18F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging (2011) (70)
PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue. (2011) (69)
VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. (2013) (69)
Engineered Mesenchymal Stem Cells with Enhanced Tropism and Paracrine Secretion of Cytokines and Growth Factors to Treat Traumatic Brain Injury (2015) (69)
Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat (2018) (67)
Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. (2012) (67)
Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy. (2018) (66)
Dotted Core–Shell Nanoparticles for T1‐Weighted MRI of Tumors (2018) (66)
Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery (2016) (66)
The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development. (2014) (64)
PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714 (2014) (64)
Targeted Therapeutic Nanotubes Influence the Viscoelasticity of Cancer Cells to Overcome Drug Resistance (2014) (63)
First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using 68Ga-IRDye800CW-BBN (2018) (63)
Rational design of a super-contrast NIR-II fluorophore affords high-performance NIR-II molecular imaging guided microsurgery† †Electronic supplementary information (ESI) available: Synthesis optimization process and structure characterization, excretion study, binding affinity, etc. See DOI: 10.1039 (2018) (63)
Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy (2018) (63)
In Situ shRNA Synthesis on DNA–Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (2018) (62)
Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies. (2019) (61)
PET Imaging of Tenascin-C with a Radiolabeled Single-Stranded DNA Aptamer (2015) (60)
Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma (2012) (60)
18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy (2011) (59)
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors (2018) (59)
Preclinical Lymphatic Imaging (2011) (58)
A ketogenic diet increases brown adipose tissue mitochondrial proteins and UCP1 levels in mice (2013) (58)
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors. (2018) (58)
68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer (2015) (58)
High-affinity peptide against MT1-MMP for in vivo tumor imaging. (2011) (58)
Rapid and simple one-step F-18 labeling of peptides. (2011) (56)
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer (2018) (56)
Protein-based photothermal theranostics for imaging-guided cancer therapy. (2015) (56)
18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression (2015) (56)
Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells (2020) (55)
Tumour microenvironment-responsive semiconducting polymer-based self-assembly nanotheranostics. (2019) (54)
Biomimetic RNA-silencing nanocomplexes: overcoming multidrug resistance in cancer cells. (2014) (53)
PET Imaging of Angiogenesis. (2009) (52)
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding (2016) (52)
Quantitative Analysis and Comparison Study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model (2012) (52)
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer (2018) (52)
Multiplex imaging of an intracellular proteolytic cascade by using a broad-spectrum nanoquencher. (2012) (52)
18 F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases (2015) (51)
Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB (2015) (50)
Multimodality Imaging of Tumor Response to Doxil (2011) (50)
Dual-enhanced photothermal conversion properties of reduced graphene oxide-coated gold superparticles for light-triggered acoustic and thermal theranostics. (2016) (50)
Pilot Prospective Evaluation of 18F-Alfatide II for Detection of Skeletal Metastases (2015) (50)
Molecular imaging of microRNAs (2011) (48)
MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides (2010) (47)
PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients (2017) (46)
Longitudinal PET Imaging of Doxorubicin-Induced Cell Death with 18F-Annexin V (2012) (45)
DNA-inorganic hybrid nanovaccine for cancer immunotherapy. (2016) (45)
Longitudinal PET Imaging of Muscular Inflammation Using 18F-DPA-714 and 18F-Alfatide II and Differentiation with Tumors (2014) (44)
Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging. (2011) (44)
Evaluation of 64Cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor Vasculature (2012) (44)
Non-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor (2008) (44)
Novel “Add-On” Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents (2017) (43)
Preclinical molecular imaging of tumor angiogenesis. (2010) (42)
68Ga-NOTA-Aca-BBN(7–14) PET/CT in Healthy Volunteers and Glioma Patients (2016) (42)
Improvement of CXCR4 tracer specificity for PET imaging. (2012) (42)
18F-Alfatide II and 18F-FDG Dual-Tracer Dynamic PET for Parametric, Early Prediction of Tumor Response to Therapy (2014) (42)
Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer. (2017) (41)
Optical Imaging of Integrin αvβ3 Expression with Near-Infrared Fluorescent RGD Dimer with Tetra(ethylene glycol) Linkers (2010) (40)
Differentiation of Reactive and Tumor Metastatic Lymph Nodes with Diffusion-weighted and SPIO-Enhanced MRI (2013) (40)
Boramino acid as a marker for amino acid transporters (2015) (40)
Core-shell metal-organic frameworks with fluorescence switch to trigger an enhanced photodynamic therapy (2019) (39)
PET imaging of early response to the tyrosine kinase inhibitor ZD4190 (2011) (39)
Multimodality Imaging of IL-18–Binding Protein-Fc Therapy of Experimental Lung Metastasis (2008) (39)
In vivo quantitative photoacoustic microscopy of gold nanostar kinetics in mouse organs (2014) (38)
PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model (2012) (37)
Phage Display–Derived Peptides for Osteosarcoma Imaging (2010) (37)
Comparison of Three Dimeric 18F-AlF-NOTA-RGD Tracers (2014) (36)
Lymphatic Imaging: Focus on Imaging Probes (2015) (36)
Prospective Study of 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients (2015) (36)
X‐ray‐Controlled Bilayer Permeability of Bionic Nanocapsules Stabilized by Nucleobase Pairing Interactions for Pulsatile Drug Delivery (2019) (35)
Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging (2020) (34)
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG. (2018) (33)
Novel 19F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS (2014) (33)
Has Molecular and Cellular Imaging Enhanced Drug Discovery and Drug Development? (2008) (32)
Development of Sialic Acid-coated Nanoparticles for Targeting Cancer and Efficient Evasion of the Immune System (2017) (32)
Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging (2012) (32)
Molecular Imaging with Activatable Reporter Systems (2012) (32)
Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer (2014) (32)
Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe (2012) (31)
Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression. (2008) (31)
Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). (2013) (30)
Longitudinal Bioluminescence Imaging of the Dynamics of Doxorubicin Induced Apoptosis (2013) (30)
Molecular imaging of cell-based cancer immunotherapy. (2011) (30)
Amphiphilic-Polymer-Guided Plasmonic Assemblies and Their Biomedical Applications. (2017) (30)
Quantitative Analysis and Parametric Imaging of 18F-Labeled Monomeric and Dimeric RGD Peptides Using Compartment Model (2012) (29)
Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide (2011) (28)
Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer. (2019) (27)
Monitoring Tumor Hypoxia Using 18F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy (2016) (27)
Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging (2017) (27)
64Cu-Labeled PEGylated Polyethylenimine for Cell Trafficking and Tumor Imaging (2009) (27)
Hierarchical Assembly of Bioactive Amphiphilic Molecule Pairs into Supramolecular Nanofibril Self-Supportive Scaffolds for Stem Cell Differentiation. (2016) (26)
Tumor Microenvironment-Activated Ultrasensitive Nanoprobes for Specific Detection of Intratumoral Glutathione by Ratiometric Photoacoustic Imaging. (2019) (26)
Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. (2011) (26)
Polymeric Nanovehicle Regulated Spatiotemporal Real-Time Imaging of the Differentiation Dynamics of Transplanted Neural Stem Cells after Traumatic Brain Injury. (2015) (26)
In Vivo Bioluminescence Tumor Imaging of RGD Peptide-modified Adenoviral Vector Encoding Firefly Luciferase Reporter Gene (2007) (26)
Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema (2017) (26)
An Albumin-Binding T1- T2 Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging. (2019) (25)
PET of Glucagonlike Peptide Receptor Upregulation After Myocardial Ischemia or Reperfusion Injury (2012) (25)
18F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study (2018) (25)
Bioinspired Nanocomplex for Spatiotemporal Imaging of Sequential mRNA Expression in Differentiating Neural Stem Cells (2014) (25)
One-Pot Two-Step Radiosynthesis of a New 18F-Labeled Thiol Reactive Prosthetic Group and Its Conjugate for Insulinoma Imaging (2014) (25)
A Symmetrical Fluorous Dendron‐Cyanine Dye‐Conjugated Bimodal Nanoprobe for Quantitative 19F MRI and NIR Fluorescence Bioimaging (2014) (24)
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography (2017) (24)
Site-specifically biotinylated VEGF(121) for near-infrared fluorescence imaging of tumor angiogenesis. (2009) (23)
New Methods for Labeling RGD Peptides with Bromine-76 (2011) (23)
A role for phosphodiesterase 3B in acquisition of brown fat characteristics by white adipose tissue in male mice. (2013) (23)
Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression (2013) (22)
Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity. (2014) (22)
PEGylated Exendin-4, a Modified GLP-1 Analog Exhibits More Potent Cardioprotection than Its Unmodified Parent Molecule on a Dose to Dose Basis in a Murine Model of Myocardial Infarction (2015) (22)
Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation. (2019) (22)
[18F]DPA-714 PET Imaging of AMD3100 Treatment in a Mouse Model of Stroke (2014) (22)
EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models (2016) (21)
Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression (2016) (21)
PET imaging of EGFR expression using an 18F-labeled RNA aptamer (2019) (21)
Molecular targeting of CEACAM6 using antibody probes of different sizes. (2012) (20)
Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment. (2011) (20)
Combined image guided monitoring the pharmacokinetics of rapamycin loaded human serum albumin nanoparticles with a split luciferase reporter. (2016) (19)
Self-assembly of gold nanoparticles to silver microspheres as highly efficient 3D SERS substrates (2013) (19)
Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas. (2013) (19)
Phage display peptide probes for imaging early response to bevacizumab treatment (2011) (19)
Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI. (2012) (18)
The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40 (2019) (18)
Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy. (2018) (18)
A cyclic HSV1-TK reporter for real-time PET imaging of apoptosis (2014) (18)
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7–14 and Antagonist RM26 (2017) (17)
Converting Red Blood Cells to Efficient Microreactors for Blood Detoxification (2017) (17)
Upregulation of TRAG3 gene in urothelial carcinoma of the bladder (2011) (17)
Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions. (2011) (17)
Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions (2019) (16)
A Logic-Gated Modular Nanovesicle Enables Programmable Drug Release for On-Demand Chemotherapy (2019) (16)
Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene. (2015) (13)
Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. (2012) (13)
Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers. (2010) (13)
PET-Guided Evaluation and Optimization of Internalized Antibody–Drug Conjugates Targeting Erythropoietin-Producing Hepatoma A2 Receptor (2017) (12)
RGD PET: From Lesion Detection to Therapy Response Monitoring (2016) (12)
Resection and survival data from a clinical trial of glioblastoma multiforme‐specific IRDye800‐BBN fluorescence‐guided surgery (2020) (12)
Dual-factor triggered fluorogenic nanoprobe for ultrahigh contrast and subdiffraction fluorescence imaging. (2013) (12)
When radionuclides meet nanoparticles (2018) (12)
Ultrasmall Quantum Dots with Broad‐Spectrum Metal Doping Ability for Trimodal Molecular Imaging (2019) (11)
An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides. (2019) (11)
Preclinical evaluation of an 18F-trifluoroborate methionine derivative for glioma imaging (2018) (11)
Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma (2018) (10)
PET of Insulinoma using 18 F-FBEM-EM3106B, a New GLP-1 Analog (2011) (10)
Biomedical Applications: Single Continuous Wave Laser Induced Photodynamic/Plasmonic Photothermal Therapy Using Photosensitizer‐Functionalized Gold Nanostars (Adv. Mater. 22/2013) (2013) (10)
68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma (2019) (9)
First-inhuman study of PET and optical dual-modality image-guided surgery in glioblastoma using 68 Ga-IRDye 800 CW-BBN (2018) (9)
LC/MS evaluation of metabolism and membrane transport of bombesin peptides (2011) (9)
Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS (2012) (9)
N-Succinimidyl 4-[18F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression (2012) (8)
Correction: Delayed Postconditioning Protects against Focal Ischemic Brain Injury in Rats (2009) (8)
Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain (2011) (7)
From protein-protein interaction to therapy response: molecular imaging of heat shock proteins. (2009) (7)
Polyphenol-based nanoplatform for MRI/PET dual-modality imaging guided effective combination chemotherapy. (2019) (7)
Imaging tumor endothelial marker 8 using an 18F-labeled peptide (2011) (7)
Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET (2015) (6)
Noninvasive Visualization of microRNA by Bioluminescence Imaging (2009) (6)
Size effect in molecular imaging of vascular endothelial growth factor. (2011) (4)
Novel molecular “add-on” based on Evans Blue confers superior pharmacokinetics and transforms drugs to theranostic agents (2016) (4)
Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel. (2012) (4)
Correction to Design Considerations of Iron-Based Nanoclusters for Noninvasive Tracking of Mesenchymal Stem Cell Homing (2014) (4)
Correction to “Novel 19F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS” (2017) (4)
Design of a functional cyclic HSV1-TK reporter and its application to PET imaging of apoptosis (2015) (4)
The Role of Molecular Imaging in Drug Delivery. (2009) (4)
Antidiabetic Effect of Abextide, a Long‐Acting Exendin‐4 Analogue in Cynomolgus Monkeys (2018) (3)
Biomedical Applications: Ultrasmall Gold Nanorod Vesicles with Enhanced Tumor Accumulation and Fast Excretion from the Body for Cancer Therapy (Adv. Mater. 33/2015) (2015) (3)
Corrigendum: N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient siRNA Delivery (2011) (3)
PET imaging of glucagon-like peptide receptor upregulation after myocardial ischemia/reperfusion injury (2012) (3)
Protein Tyrosine Kinase-7 Expression (2015) (3)
First-in-Human Study of a64Cu-Labeled Long-acting Integrin αvβ3 Targeting Molecule64Cu-NOTA-EB-RGD in Healthy Volunteers and GBM Patients (2020) (3)
Abstract 5273: Multiplexed PET probes for imaging breast cancer early response to VEGF121/rGel treatment (2011) (2)
A metabolically stable leucine mimic identifies cancer from inflammation with positron emission tomography (2016) (2)
RESEARCH ARTICLE 64 Cu-Labeled PEGylated Polyethylenimine for Cell Trafficking and Tumor Imaging (2009) (2)
Longitudinal PET Imaging of Muscular Inflammation Using 18 F-DPA-714 and 18 F-Alfatide II and Differentiation (2014) (2)
Back Cover: Acetylcholinesterase‐Catalyzed Hydrolysis Allows Ultrasensitive Detection of Pathogens with the Naked Eye (Angew. Chem. Int. Ed. 52/2013) (2013) (2)
In Vivo Imaging: Multiplexed NIR‐II Probes for Lymph Node‐Invaded Cancer Detection and Imaging‐Guided Surgery (Adv. Mater. 11/2020) (2020) (2)
Site-specifically biotinylated VEGF121 for tumor angiogenesis imaging (2008) (2)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy (2017) (2)
64Cu-Labeled polyethyleneimine (PEI) for cell trafficking and tumor imaging (2008) (2)
Striatal adenosine A2A receptor mediated PET Imaging in 6- hydroxydopamine lesioned rats using [18F]-MRS5425 (2011) (1)
Comparison of F-18-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression (vol 15, pg 758, 2013) (2013) (1)
Erratum to: Comparison of 18F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression (2013) (1)
Superparamagnetic Nanoparticles: N‐Alkyl‐PEI‐Functionalized Iron Oxide Nanoclusters for Efficient siRNA Delivery (Small 19/2011) (2011) (1)
Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy (2017) (1)
Applications of Small-Animal Molecular Imaging in Drug Development (2014) (1)
WE-C-217BCD-04: Multimodality Imaging of Breast Cancer Experimental Lung Metastasis. (2012) (1)
Back Cover: Sticky Nanoparticles: A Platform for siRNA Delivery by a Bis(zinc(II) dipicolylamine)‐Functionalized, Self‐Assembled Nanoconjugate (Angew. Chem. Int. Ed. 2/2012) (2012) (1)
An Improved Prostate Specific Membrane Antigen Targeting Agent for Prostate Cancer Imaging and Therapy (2018) (1)
Correction to Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy. (2019) (1)
PET imaging of insulinoma using 18F-FBEM-EM3106 B, a new GLP-1 analog (2011) (1)
Longitudinal analysis of PET imaging with Cu-64-labeled collagen specific peptides for the detection of collagen in myocardial fibrosis in rats (2014) (1)
Correction to: PET imaging of EGFR expression using an 18F-labeled RNA aptamer (2018) (1)
Longitudinal PET imaging of doxorubicin induced apoptosis with 18F-annexin V in a xenografted model (2012) (1)
Integrin AvB3-Targeted Radioimmunotherapy of Glioblastoma (2008) (1)
Erratum to: LC/MS evaluation of metabolism and membrane transport of bombesin peptides (2011) (0)
Multimodality longitudinal imaging of tissue remodeling in a murine hindlimb ischemia model (2013) (0)
Rücktitelbild: Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells (Angew. Chem. 7/2014) (2014) (0)
Tumor-Speci fi c Formation of Enzyme-Instructed Supramolecular Self-Assemblies as Cancer Theranostics A RTIC LE (2017) (0)
MicroPET imaging of urokinase-type plasminogen activator receptor (uPAR) expression using a 64Cu-labeled uPAR-binding peptide (2007) (0)
Gastrin-releasing peptide receptor PET imaging with 68Ga-NOTA-Aca-BBN (7-14) and 68Ga-NOTA-IRDye800CW-BBN for evaluation of glioma patients: A prospective pilot study (2018) (0)
Erratum: A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface (Chemical Communications (2012) 48 (9768-9770) (DOI: 10.1039/c2cc31974h)) (2012) (0)
(335) Decreased opioid receptor availability in rat brain three months after peripheral nerve injury. (2016) (0)
Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS (2012) (0)
Mapping Sentinel Lymph Node Metastasis by Optical Imaging (2016) (0)
Early stratification of radiotherapy response by activatable inflammation magnetic resonance imaging (2020) (0)
[18F]FPRGD2 imaging of abraxane therapy response (2009) (0)
Non-invasive PET imaging of downregulation of HER-2 in 17-DMAG treated ovarian cancers (2009) (0)
PET imaging of CEACAM6 expression with an F-18 labeled single domain antibody (2013) (0)
Trimodal molecular imaging using a broad-spectrum metal attaching ultra-small quantum dots (2019) (0)
In vivo labeling of serum albumin for positron emission tomography (2014) (0)
Monitor Therapeutic Response of Human Ovarian Cancer to 17-DMAG by Non-invasive PET imaging with 64 Cu-DOTA-Trastuzumab (2013) (0)
Cancer Phototherapy: Multimodal‐Imaging‐Guided Cancer Phototherapy by Versatile Biomimetic Theranostics with UV and γ‐Irradiation Protection (Adv. Mater. 17/2016) (2016) (0)
Multimodality imaging to monitor IL-18bp-Fc-IL-1ra fusion protein treatment of breast cancer experiment lung metastasis (2007) (0)
Synthesis and PET imaging of [64Cu]GX1: A phage display peptide probe for detecting tumor vasculature (2010) (0)
Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells (2020) (0)
Molecular Imaging of Apoptosis in Cancer (2012) (0)
Polymeric Materials for Theranostic Applications (2013) (0)
Quantification of Tumor Vascular Permeability by Positron Emission Tomography with [18F]FAl-NEB (2016) (0)
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study (2018) (0)
Clinical translation of a dual integrin α v β 3 and GRPR targeting PET radiotracer 68 Ga-BBN-RGD (2016) (0)
Metabolite profiling and rational design of an MMP activatable probe by LC/MS (2013) (0)
SAT-575 Radiolabeled Somatostatin Receptor Analog 86Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 in Thyroid Cancer Mice Models (2019) (0)
Mitochondrial Biogenesis and Increased Uncoupling Protein 1 in Brown Adipose Tissue of Mice Fed a Ketone Ester Diet (2012) (0)
microPET imaging of urokinase-type plasminogen activator receptor expression using 64Cu-labeled cyclo19,31[D-Cys19]uPA19-31 (2007) (0)
Rücktitelbild: Sticky Nanoparticles: A Platform for siRNA Delivery by a Bis(zinc(II) dipicolylamine)-Functionalized, Self-Assembled Nanoconjugate (Angew. Chem. 2/2012) (2012) (0)
Multidrug Resistance: In Situ shRNA Synthesis on DNA–Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (Adv. Mater. 10/2018) (2018) (0)
Quantitative analysis and parametric mapping of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using graphical method (2012) (0)
Lymph Nodes Mapping with a Novel Long-lasting Evans Blue (2018) (0)
Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy (2017) (0)
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain (2010) (0)
Bio-AFM of Cancer Cells and Multifunctional Theranostics (2016) (0)
Spatiotemporal molecular imaging of dynamic differentiation of transplanted neural stem cells in traumatic brain injury (2014) (0)
Albumin-binding PET radiotracer 68Ga-NEB for diagnosing hepatic hemangioma (2015) (0)
Tumor therapy response monitoring with 18F-Alfatide and 18F-FDG dual tracer dynamic PET (2013) (0)
Molecular imaging of CEACAM6 using antibody probes of different sizes (2011) (0)
Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and superparamagnetic iron oxide enhanced MRI (2012) (0)
Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide (2011) (0)
Back Cover: Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells (Angew. Chem. Int. Ed. 7/2014) (2014) (0)
Rücktitelbild: Acetylcholinesterase-Catalyzed Hydrolysis Allows Ultrasensitive Detection of Pathogens with the Naked Eye (Angew. Chem. 52/2013) (2013) (0)
Radiopharmaceuticals and Medical Imaging: Development of Radioimmumoconjugates for Radioimmunoimaging and Radioimmunotherapy of Malignant Diseases (2011) (0)
Imaging Heat Shock Protein 90 (Hsp90) Activity in Hormone-Refractory Prostate Cancer (2009) (0)
Dual-modality GRPR targeting PET and optical image-guided surgery in lower grade glioma using 68Ga-IRDye800CW-BBN (2018) (0)
Dual Gastrin-Releasing Peptide Receptor and Integrin αvβ3 targeting PET/CT using 68Ga-BBN-RGD in Patients with Breast Cancer (2018) (0)
Evaluation of in vitro metabolism and membrane transport by LC/MS: Application to agonistic and antagonistic gastrin-releasing peptide receptor (GRPR) imaging ligands (2010) (0)
N-Succinimidyl 4-[18F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gang Niu?

Gang Niu is affiliated with the following schools:

Gang Niu's Academic­Influence.com Rankings

Gang Niu's Degrees

Why Is Gang Niu Influential?

Gang Niu's Published Works

Published Works

What Schools Are Affiliated With Gang Niu?

Gang Niu's AcademicInfluence.com Rankings